Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Yao Xue Xue Bao ; 47(7): 909-15, 2012 Jul.
Article in Chinese | MEDLINE | ID: mdl-22993856

ABSTRACT

Through protein-protein BLAST of homologous sequences in different species in NCBI database and preliminary simulating molecular docking and molecular dynamics by computer software discovery studio 3.1, three amino acids R25K26K27 of natural human parathyroid hormone (1-34) with Q25E26L27 were mutated and the biological activity of the mutant peptide was evaluated. Result showed that: root mean superposition deviation RMSD value between PTH (1-34)-(RKK-QEL) and PTH (1-34) peptide main chain was 2.509 3, indicating that the differences between the two main chain structural conformation was relatively small; the interaction energy between PTH (1-34)-(RKK-QEL) and its receptor protein PTH1R had been enhanced by 7.5% compared to nature PTH (1-34), from -554.083 kcal x mol(-1) to -599.253 kcal x mol(-1); the number of hydrogen bonds was increased from 32 to 38; PTH (1-34)-(RKK-QEL) can significantly stimulate the RANKL gene expression (P < 0.01) while inhibiting the OPG gene expression (P < 0.01) in UAMS-32P cells; in the co-culture system of UAMS-32P cells and mouse primary femur bone marrow cells, PTH (1-34)-(RKK-QEL) stimulated the formation of osteoclasts (P < 0.01) and had a higher biological activity than PTH (1-34) standard reagents.


Subject(s)
Mutant Proteins/genetics , Mutation , Osteoprotegerin/metabolism , RANK Ligand/metabolism , Teriparatide/pharmacology , Animals , Bone Marrow Cells/cytology , Bone Marrow Cells/metabolism , Coculture Techniques , Mice , Mutant Proteins/pharmacology , Osteoclasts/cytology , Osteoclasts/drug effects , Osteogenesis/drug effects , Osteoprotegerin/genetics , RANK Ligand/genetics , RNA, Messenger/metabolism , Receptor, Parathyroid Hormone, Type 1/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...